2023 Attendee Profile

Now in its 15th year of fostering these joint efforts to advance our medical knowledge inclusive of all stakeholders, SCOPE Summit 2024 will take place February 11-14, 2024, in Orlando, FL at the Rosen Shingle Creek. Over four stimulating days of in-depth discussions and networking in 28 different conferences, a bustling exhibit hall with 200 companies, 3 plenary keynote sessions, the 8th annual Participant Engagement Awards, the inaugural Site Innovation Award, special cross-department panels, the 3rd annual Master of Clinical Research golf tournament, a Big Game Tailgate Party, and a boutique investor conference, the programming focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management, operations, and investment. SCOPE welcomes more than 3,300 attendees, 850 different organizations, from 27 countries, in clinical operations, clinical trials, innovation, and research.

Additional SCOPE Offerings

Join SCOPE LinkedIn Group
Join ClinEco
SCOPE of Things Podcast
Clinical Research News

Hear what a few people had to say about SCOPE Summit 2023:

The SCOPE 2023 conference marked an exciting inflection point for the clinical trial industry as the future of clinicaltrials is unfolding. With the caliber of tracks, sessions, speakers, panels resulting in timely and provocative topics, SCOPE has become an important meeting that can't be missed. I left the conference thinking about how much we as an industry have evolved, how much more there is to do and how SCOPE is a great meeting place for advancing the industry.
Founder, Hawthorne Effect, Inc.

It was truly a pleasure participating in this excellent SCOPE Investor and Innovation Conference. It was my first SCOPE experience and I will be back!
Global Head, Healthcare + Life Sciences, Amazon Web Services LLC

Software innovation in the clinical domain, and pharma more broadly, is one of our top priorities – SCOPE is a fantastic venue to get together with thought leaders, innovators, and of course our portfolio companies sharing our passion for the space”
Vice President, Insight Partners

It was really worth the time and effort to come back to SCOPE after 7 years and I was just delighted to see the growth over these years. The sessions were informative, and the Exhibit hall filled with emerging and established organizations, many of whom I interacted with over the 4 days.
Head, Clinical Partner Management

I really enjoyed SCOPE over the years. I have attended four times so far. The topics are innovative and cutting edge and it is cross functional.
PhD, Senior Director and Head of Statistical Innovation Statistical Sciences and Analytics Data and
Statistical Sciences, Abbvie

This was my first SCOPE US and I enjoyed it very much – it was great to meet so many new people, connect names to faces and have thought-provoking discussions.
Senior Director, AstraZeneca

It was my first SCOPE Investor and Innovation Conference and it was such an eye-opening event to meet talents with very different background to discuss the achievement and future gaps in Clinical Research, Digital Health, Health Service Providers. The network opportunity is amazing!
PhD, Managing Director, Boehringer Ingelheim Venture Fund

I appreciate the opportunity provided to me to attend and present at SCOPE Summit. This is a wonderful event and I loved every bit of the ideas shared by the many speakers on the evolving landscape of clinical trials and also to hear from other therapeutic areas in the Lifesciences and BioPharma industry.
Sr. Manager, Clinical Systems, Transcatheter Mitral & Tricuspid Therapies

The pleasure is all mine to participate as a chair and speaker at the Summit. I always learn so much about the current trends in clinical research and look forward to seeing new innovation.
Clinical Research Project, NIH, NINDS

This was first time attending SCOPE for me and I was very impressed by the quality and breadth of topics discussed. I got great questions and excellent follow-up networking and requests for more data around patient engagement, and minorities recruitment. Several of people from audiences asked if they could see any follow-up data on these topics and the cancer moonshot project in general in the next SCOPE meeting.
Program Director, Biorepositories and Biospecimen Research Branch (BBRB), Cancer Diagnosis
Program Division of Cancer Treatment and Diagnosis, National Cancer Institute

Nothing compares to bringing together startups, investors and ultimate acquirers/customers in a specific market. The SCOPE Investor track delivered this in spades for the clinical trial market.”
Founder & Managing Partner, SPRIG Equity

I wanted to thank you for the opportunity to attend SCOPE. It was a wonderful experience. I learned so much and left with so many ideas, connections,and a world record certificate.
Clinical Research, Fordham School of Social Service

I wanted to express our sincerest thanks for all the hard work in organizing SCOPE. Your team’s professionalism, attention to detail, and commitment to excellence were evident throughout the event and it was an absolute pleasure to be a part of it!
Product Marketing Manager, StudyKIK

THANK YOU!!!!! Such a fun event.The SCOPE conference was absolutely incredible this year. Thanks for the wonderful opportunity and looking forward to participating in the conference in 2024.
Vice President, Clinical Site Start Up, Site Engagement, Trial Optimization, Takeda

SCOPE 2022 Highlights

SCOPE Summit Europe

2024 Conference Programs

Clinical Trial Tech: Venture, Innovation & Partnering
*Separate Registration Required